Drug delivery, formulation

14 Sep 2023 Thursday

ReciBioPharm - An optimized Plasmid DNA platform to accelerate the path to clinic and commercialization

Recipharm AB | Webinar

Assessing key parameters of the upstream process to achieve high titer while maintaining desired integrity
Customizing the downstream process to...

Register for free

How enhancing equipment reliability supports quality, efficiency, and operational excellence

Content provided by Bora Pharmaceuticals | 10-Aug-2023 | White Paper

Successfully manufacturing a drug product requires people, proper equipment, and materials. It’s the classic three-legged stool analogy. Even with well-trained...

State-of-the-Art Virtual Pharma Factory Tour

Content provided by METTLER TOLEDO | 09-Jun-2023 | Event Programme

Join METTLER TOLEDO’s weighing experts on a virtual tour of a state-of-the-art manufacturing facility. On the call, you'll be digitally transported...

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

Drug Solubility and the Need for Speed

Content provided by Lonza Small Molecules | 28-Mar-2023 | White Paper

A growing number of new chemical entities are highly insoluble, leading to problems with bioavailability. Drug manufacturers therefore have to find ways...

2023 State of Clinical Trial Technology Report

Content provided by Florence Healthcare | 01-Mar-2023 | Insight Guide

Discover the trends shaping clinical trial technology in 2023, from Site Enablement to eISFs, integrations, and site-sponsor collaboration. This report...

Sofgen Pharmaceuticals obtains Drug Establishment License

Content provided by Sofgen Pharmaceuticals | 23-Jan-2023 | Press Release

Health Canada certifies Sofgen Pharmaceuticals in Canadian Good Manufacturing Practices (GMP) for our compliance with the Food and Drug Regulations at...

Tackling Early Phase Development with First-In-Human Study Solutions

Content provided by Altasciences | 25-Oct-2022 | White Paper

Bringing new drugs to market, from lead candidate selection through preclinical testing, to clinical proof of concept, is a complex, time-consuming, and...

The Complexities of Ophthalmic Drug Development

Content provided by Altasciences | 04-Oct-2022 | White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Seasonal Vaccine Manufacturing

Content provided by Baxter BioPharma Solutions | 13-Jul-2022 | White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Formulation Effects on Tablet Surface Properties and Film Coating Adhesion

Content provided by JRS PHARMA | 01-Jul-2022 | White Paper

The aim of this study was to investigate the influence of different commonly applied lubricants and disintegrants on tablet surface and film coating adhesion....

Flexible Filling Solution for CMOs

Content provided by Single Use Support GmBH | 18-May-2022 | Insight Guide

Achieving flexibility requires modularity of technologies.

CMOs and CDMOs aspire to be flexible for multiple applications. Efficient automated...

Nanomilling for Better Solubility and Bioavailability

Content provided by Altasciences | 07-Apr-2022 | White Paper

40% of marketed drugs and 90% of active pharmaceutical ingredients (APIs) are poorly water-soluble. Nanomilling is a proven technique that can overcome...

Eastern & Western Manufacturing Solutions

Content provided by Piramal Pharma Solutions | 15-Mar-2022 | White Paper

The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from...

How Formulation Development Affects Manufacturing

Content provided by Catalent | 24-Feb-2022 | Insight Guide

Due to advances in technology and increased development of parenteral drugs, one of the fastest-growing choices for drug delivery in the pharmaceutical...

Funtrition by Procaps expands its gummy offerings with new Gummy manufacturing facility in the US

Content provided by Sofgen Pharmaceuticals | 14-Feb-2022 | Press Release

New Funtrition Gummy Manufacturing Facility in Florida Slated to be Fully Operational by Q1 2023, to Support Increased U.S. and global Demand of Advanced...

Spray Dried Powders for High Dose Drug Delivery

Content provided by Catalent | 01-Feb-2022 | Product Presentation

This Catalent webinar will explore how spray dried particles provide an attractive, carrier-free option for highly dispersed delivery of API to deep lung...

Maximizing Drug Formulation for First-In-Human Trials

Content provided by Altasciences | 13-Dec-2021 | Case Study

The manufacture of a drug product for clinical trials is of critical importance. The formulation, manufacturing, and assessment of a drug candidate during...

The Future of Innovation In Pharmaceutical Delivery Systems

Content provided by Sofgen Pharmaceuticals | 06-Dec-2021 | Product Presentation

More than 4 decades of expertise in innovative technologies and value-added pharmaceutical solutions. Procaps Group's purpose is to spread its legacy...

A Culture of Innovation as a Differentiation

Content provided by Sofgen Pharmaceuticals | 06-Dec-2021 | Product Presentation

We create safe, effective and differentiated pharmaceutical solutions and this has been our goal since day 1. The main driver of our growth is innovation...

Flexibility and capability in pre-filled syringes

Content provided by Curia | 15-Nov-2021 | White Paper

Pre-filled syringes have risen in popularity in recent years but the pandemic’s impact on drug development, manufacturing and patient care has created...

Overcoming Solubility Challenges with Liquid-Filled Capsules

Content provided by Altasciences | 28-Sep-2021 | White Paper

Poorly soluble molecules comprise more than 70% of the small molecule products entering the drug development pipeline today, and are difficult to formulate...

A Better Approach, for Better Pain Trials

Content provided by Signant Health | 27-Sep-2021 | White Paper

Pain studies face unique challenges. For one, pain severity can only be truly assessed by the patients themselves. The controlled substances that are often...

Bioavailability Enhancement Techniques to Improve Patients' Lives

Content provided by Piramal Pharma Solutions | 16-Sep-2021 | White Paper

Oral bioavailability is a constant challenge for developers of new chemical entities. Low solubility and permeability often reduce the fraction of an orally...

Transforming Clinical Development

Content provided by PerkinElmer | 01-May-2021 | White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Q&A: Effective Drug Product Process Development

Content provided by Catalent | 14-Jan-2021 | Insight Guide

In this Q&A, a Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the...

Formulation and development strategies for amorphous solid dispersions

Content provided by Lonza | 17-Sep-2020 | Sponsored Link

A large and increasing fraction of orally administered small molecules in pharma company pipelines have poor oral absorption due to low aqueous solubility...

Accelerated development of first-in-human programs. Lonza’s SimpliFiH® Solutions

Content provided by Lonza | 25-Aug-2020 | Sponsored Link

The presented program is laid out as integrated Drug Substance, Particle Engineering and Drug Product services, enabling drug substance and drug product...

Flow Cytometry Services

Content provided by Q² Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Outsourcing Analytical Testing for Biologics - A CRO's Perspective

Content provided by Frontage Laboratories | 01-Dec-2019 | White Paper

Biologics are complex large molecules derived from living organisms or manufactured from cells, and they have inherent structural heterogeneity. Indeed,...

How to Avoid Surprises in Small-Molecule Drug Development Programs

Content provided by Frontage Laboratories | 01-Oct-2019 | White Paper

Over the years, the pharmaceutical industry has made steady progress in improving the safety of drugs in development. Consequently, in 2015, only 14 percent...

Validating The Simoa Technology

Content provided by Frontage Laboratories | 01-Oct-2019 | White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Assessing Pre-Existing Antibodies in Biotheraputic Development

Content provided by Frontage Laboratories | 21-Aug-2019 | White Paper

Immunogenicity is the leading reason that biologics fail in clinical trials, and thus it has become imperative for drug development programs to include...

The Truth about Physician Referrals and Clinical Trials

Content provided by BBK Worldwide | 24-Jul-2019 | White Paper

Despite growing evidence, the myth that physicians won’t refer patients to clinical trials persists, perpetuated by the belief that they fear losing their...

Stability Testing As a Quality Control Measure

Content provided by Frontage Laboratories | 19-Jun-2019 | White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Content provided by Baxter BioPharma Solutions | 05-Nov-2018 | White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Survey Report: State of the global pharmaceutical contract services industry 2018

Content provided by William Reed | 11-Jul-2018 | Research Study

In May 2018 Outsourcing-Pharma.com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of...

Marken Delivers Compassionate Use Dose of Emergency Medication to Critical Pediatric Patient

Content provided by Marken | 26-Jun-2018 | Case Study

A desperate mother in Germany urged her team of doctors to reach out to a Marken client on behalf of her two year old girl. The child was battling leukemia...

Lyophilization Scale-Up and Tech Transfer

Content provided by Baxter BioPharma Solutions | 12-Mar-2018 | White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Process Development for Lyophilized Products

Content provided by Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Advancing therapeutics for myeloma

Content provided by Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

The Power to Make, A Virtual Tour

Content provided by Althea | 24-Mar-2017

You have the power to make a difference. To make new therapeutics that improve quality of life and inspire a healthier world. To do this, you need a manufacturing...

B. Braun OEM. Tailor-made solutions for the healthcare industry

Content provided by B. Braun Melsungen AG | 10-May-2016 | White Paper

B. Braun OEM offers standard products or customized versions. Even the standard range contains hundreds of product versions, with which countless applications...

UPLC Analysis of Methoxy & 2-Hydroxypropoxy in Hypromellose

Content provided by SGS Life Science Services | 25-Apr-2016 | White Paper

Because of its use in the pharmaceutical and food industries, the USP has established standards relating to the amount of methoxyl and 2-hydroxypropoxyl...

Data Mining At The FDA

Content provided by Oracle Health Sciences | 20-Apr-2016 | White Paper

The FDA has recommended the use of data mining to the drug industry, and their new Data Mining at FDA white paper summarizes their past and current data...

Looking for a prefilled option for your sensitive compound?

Content provided by Vetter Pharma International GmbH | 12-Apr-2016 | Product Brochure

With more sophisticated therapies coming to market, manufacturers need more options for complex, sensitive molecules. Vetter-Ject® is a patented, ready-to-use...

A Technical Insight – Extractables and Leachables Studies

Content provided by RSSL | 25-Jan-2016

Contaminants leaching from pharmaceutical container systems and product packaging has increased the awareness of the health risks posed by extractables...

World Courier tackles the last mile challenge

Content provided by World Courier | 18-Jan-2016 | Research Study

The global pharmaceutical industry will have spent more than $10 billion on cold chain logistics in 2015, getting products and clinical trial supplies...

A Structured Approach to Enhancing Bioavailability for Early Development Phase Molecules

Content provided by Catalent | 11-Jan-2016 | Insight Guide

Drug development cost, lengthier development cycles, and identifying a suitable delivery platform were identified as the top three business challenges...

An integrated solution to deliver a complex pharmaceutical assignment.

Content provided by Recipharm AB | 28-Sep-2015 | Product Brochure

Developing andmanufacturing breakthrough pharmaceuticals for a global market is always a challenge. At Recipharm, we’ve developed world-class solutions...